Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine for front-line treatment of older AML patients
NCT00358644Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2005
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in acute myeloid leukemia (AML), sponsored by Eisai Co., Ltd.. Started Mar 2005; status: completed.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00358644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358644.